05Nov 2026
Intratympanic Sodium Thiosulfate Gel Shows Potential to Preserve High-Frequency Hearing During Cisplatin Chemotherapy

Intratympanic Sodium Thiosulfate Gel Shows Potential to Preserve High-Frequency Hearing During Cisplatin Chemotherapy

A randomized controlled trial evaluated intratympanic sodium thiosulfate (STS) gel for preventing cisplatin-induced hearing loss in adults with head and neck cancer. Although STS did not significantly reduce overall ototoxicity incidence, treated ears showed smaller hearing threshold shifts at several high and extended-high frequencies.

  • #ent

Like

Save

Share